公司2025年中期营收103.16亿港元，同比增长18.5%;毛利9.46亿港元，同比减少1.8%;归母净利润7.06亿 港元，同比增长9.8%。公司保持稳健增长派息政策，中期每股派息0.19港元，同比增长26.7%。公司中 期业绩符合预期。 三大核心业务贡献主要收入和利润 智通财经APP获悉，兴证国际发布研报称，中烟香港(06055)业绩稳健，通过产品结构和营业模式优化提 升盈利能力，同时保持稳健增长的派息回馈股东，公司将继续发挥中烟海外业务整合平台的作用。该行 预计公司2025/2026年公司营业收入分别为153.90/164.70亿港元，归母净利润分别为9.46/10.63亿港元， 给予"买入"评级。 兴证国际主要观点如下： 2025中期业绩符合预期，每股派息持续增长 烟叶类产品出口业务：该业务2025年中期收入11.56亿港元，同比增长25.9%，毛利63.1百万港元，同比 增长124.1%，主要由于公司积极拓展新市场新客户，出口数量和单价都有所提升。 卷烟出口业务盈利能力持续提升：截至2025年中期公司卷烟出口业务收入5.52亿港元，同比增长0.8%， 毛利1.42亿港元，同比增长16.8%，毛利率 ...

兴证国际发布研报称，中烟香港(06055)业绩稳健，通过产品结构和营业模式优化提升盈利能力，同时 保持稳健增长的派息回馈股东，公司将继续发挥中烟海外业务整合平台的作用。该行预计公司 2025/2026年公司营业收入分别为153.90/164.70亿港元，归母净利润分别为9.46/10.63亿港元，给予"买 入"评级。 兴证国际主要观点如下： 2025中期业绩符合预期，每股派息持续增长 公司2025年中期营收103.16亿港元，同比增长18.5%;毛利9.46亿港元，同比减少1.8%;归母净利润7.06亿 港元，同比增长9.8%。公司保持稳健增长派息政策，中期每股派息0.19港元，同比增长26.7%。公司中 期业绩符合预期。 三大核心业务贡献主要收入和利润 公司的三大核心业务烟叶类产品进口业务、烟叶类产品出口业务、卷烟出口业务收入贡献分别为 81.4%、11.2%和5.3%，合计达到98.0%;毛利贡献分别为72.6%、6.7%和15.0%，合计达到94.3%。 烟叶类产品进口业务：公司的烟叶类产品进口业务2025年中期收入83.99亿港元，同比增长23.5%，毛利 6.87亿港元，同比减少7.7%，毛利下降主 ...

Core Viewpoint - The company reported strong revenue growth and stable profits for the first half of 2025, driven by the import and export of tobacco leaf products, as well as cigarette exports, while increasing shareholder returns through dividends [1][2][4]. Revenue Summary - The company achieved a revenue of HKD 10.32 billion, representing an 18.5% increase year-on-year [1]. - Tobacco leaf imports generated revenue of HKD 8.40 billion, up 23.5%, with an import volume of 97,900 tons, a 2.5% increase, and an average import price of HKD 8.58 million per ton, up 20.5% [1]. - Tobacco leaf exports saw revenue of HKD 1.16 billion, a 25.9% increase, with an export volume of 38,500 tons, up 12.7%, and an average export price of HKD 30,000 per ton, up 11.7% [2]. - Cigarette exports generated revenue of HKD 550 million, a slight increase of 0.8%, with an export volume of 1.019 billion sticks, down 7.9%, and an average export price of HKD 0.54 per stick, up 9.4% [2]. Profitability Summary - The net profit for the first half of 2025 was HKD 706 million, reflecting a 9.8% increase, with a gross margin of 9.2%, down 1.9 percentage points [1]. - The gross margin for tobacco leaf imports was 8.2%, down 2.8 percentage points, primarily due to increased costs from CBT-sourced tobacco exceeding sales price increases [1]. - The gross margin for tobacco leaf exports improved to 5.5%, up 2.4 percentage points, due to enhanced pricing strategies and market expansion efforts [2]. - The gross margin for cigarette exports increased to 25.7%, up 3.5 percentage points, despite a decline in export volume [2]. Dividend and Future Outlook - The company proposed an interim dividend of HKD 0.19 per share, representing a 27% increase [1]. - The profit forecast for 2025-2027 has been raised, with expected net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% respectively [4]. - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the years 2025, 2026, and 2027, with corresponding PE ratios of 27, 25, and 22 [4].

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The revenue growth was primarily driven by the import and export of tobacco leaf products and cigarette exports, while the net profit increase was attributed to improved profitability in cigarette and tobacco leaf exports, alongside a significant reduction in financing costs by 28% [1] - The company plans to distribute an interim dividend of HKD 0.19 per share, representing a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with an export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue increased by 0.8% to HKD 550 million, with an export volume of 1.019 billion sticks (-7.9%) and an average export price of HKD 0.54 per stick (+9.4%). The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with an export volume of 81 million sticks (-65.4%) and an average export price of HKD 0.18 per stick (-3.0%). The gross margin remained at 5.5% [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with an export volume of 7,900 tons (-34.8%) and an average export price of HKD 24,600 per ton (-23.8%). The gross margin improved to 27.4% [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding PE ratios of 27, 25, and 22 times [1][4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The growth in revenue is primarily driven by the import and export of tobacco leaf products, as well as cigarette exports, while the net profit growth is attributed to improved profitability in cigarette and tobacco leaf exports and a significant reduction in financing costs by 28% [1][2] - The company plans to distribute an interim dividend of HKD 0.19 per share, representing a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue increased by 0.8% to HKD 550 million, with export volume declining by 7.9% to 1.019 billion sticks, while the average export price rose by 9.4% to HKD 0.54 per stick. The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with export volume down by 65.4% to 81 million sticks, primarily due to geopolitical conflicts and regulatory changes [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with export volume down by 34.8% to 7,900 tons, affected by extreme weather and product mix changes [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding P/E ratios of 27, 25, and 22 [1][4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a strong revenue growth of 18.5% year-on-year, reaching HKD 10.32 billion in the first half of 2025, with a net profit increase of 9.8% to HKD 706 million [1][2] - The growth in revenue is primarily driven by the import and export of tobacco leaf products and cigarette exports, while the net profit increase is attributed to improved profitability in cigarette and tobacco leaf exports, alongside a significant reduction in financing costs by 28% [1][2] - The company plans to distribute an interim dividend of HKD 0.19 per share, reflecting a 27% increase [1] Revenue Breakdown - Tobacco Leaf Imports: Revenue increased by 23.5% to HKD 8.4 billion, with an import volume of 97,900 tons (+2.5%) and an average import price of HKD 85,800 per ton (+20.5%). The gross margin decreased to 8.2% due to cost increases outpacing sales price increases [1] - Tobacco Leaf Exports: Revenue rose by 25.9% to HKD 1.16 billion, with export volume of 38,500 tons (+12.7%) and an average export price of HKD 30,000 per ton (+11.7%). The gross margin improved to 5.5% [2] - Cigarette Exports: Revenue slightly increased by 0.8% to HKD 550 million, with export volume declining by 7.9% to 1.019 billion sticks, while the average export price rose by 9.4% to HKD 0.54 per stick. The gross margin improved to 25.7% [2] - New Tobacco Exports: Revenue fell by 66.5% to HKD 15 million, with export volume down by 65.4% to 81 million sticks, primarily due to geopolitical conflicts and regulatory changes [3] - Brazilian Operations: Revenue decreased by 50.3% to HKD 195 million, with export volume down by 34.8% to 7,900 tons, affected by extreme weather and product mix changes [3] Financial Forecasts - The company has raised its profit forecasts, expecting net profits of HKD 940 million, HKD 1.04 billion, and HKD 1.18 billion for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 9.6%, 11.4%, and 12.9% [1][4] - The diluted EPS is projected to be HKD 1.35, HKD 1.51, and HKD 1.70 for the same years, with corresponding P/E ratios of 27, 25, and 22 [1][4]

Core Viewpoint - The company reported a strong performance in the first half of 2025, with significant revenue growth driven by the tobacco leaf import and export business, despite challenges in certain segments [1][2][3][4]. Financial Performance - In H1 2025, the company achieved revenue of HKD 10.316 billion, a year-on-year increase of 18.5% [1]. - The net profit attributable to equity holders was HKD 706 million, reflecting a 9.8% increase compared to the previous year [1]. - A mid-term dividend of HKD 0.19 per share was declared, up 26.7% year-on-year [1]. Business Segment Analysis - **Tobacco Leaf Export Business**: Revenue reached HKD 1.156 billion, up 25.9% year-on-year, with a gross margin of 5.5%, an increase of 2.4 percentage points [1]. - **Tobacco Leaf Import Business**: Revenue was HKD 8.399 billion, a 23.5% increase year-on-year, with a gross margin of 8.2%, down 2.8 percentage points [1]. - **Cigarette Export Business**: Revenue was HKD 552 million, a slight increase of 0.8% year-on-year, with a gross margin of 25.7%, up 3.5 percentage points [2]. - **New Tobacco Products Export Business**: Revenue fell to HKD 15 million, a decline of 66.5% year-on-year, with a gross margin of 5.3% [2]. - **Brazil Operations**: Revenue dropped to HKD 195 million, down 50.3% year-on-year, but gross margin improved to 27.4%, up 10.2 percentage points [3]. Strategic Advantages - The company holds exclusive rights for international tobacco business operations as designated by China National Tobacco Corporation, providing a rare competitive advantage [4]. - The business model demonstrates strong cash flow and pricing power, supported by the backing of China National Tobacco Group [4]. - Future growth opportunities may arise from potential acquisitions of overseas tobacco brands and channels [4]. Profit Forecast and Valuation - Revenue projections for 2025, 2026, and 2027 are estimated at HKD 15.35 billion, HKD 17.75 billion, and HKD 20.35 billion, respectively [4]. - Net profit forecasts for the same years are HKD 950 million, HKD 1.07 billion, and HKD 1.25 billion, respectively [4].

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [4][13]. Core Viewpoints - The company reported a revenue of HKD 10.316 billion for the first half of 2025, representing a year-on-year increase of 18.5%, and a net profit of HKD 706 million, up 9.8% year-on-year. The interim dividend per share was HKD 0.19, an increase of 26.7% year-on-year [1][3]. - The tobacco leaf import and export business benefited from rising tobacco leaf prices, while the self-operated proportion of the cigarette business continued to increase. The company is positioned as the exclusive operator for international business expansion and related trade for China National Tobacco Corporation, which is expected to continue driving high-quality growth [1][2]. - The company has a unique operating model with strong cash flow and bargaining power, backed by China National Tobacco Group. It is anticipated to benefit from overseas expansion and potential acquisitions in the future [2][3]. Summary by Relevant Sections Financial Performance - For the first half of 2025, the tobacco leaf export business generated revenue of HKD 1.156 billion, up 25.9% year-on-year, accounting for 11.2% of total revenue. The gross margin was 5.5%, an increase of 2.4 percentage points [8]. - The tobacco leaf import business achieved revenue of HKD 8.399 billion, a 23.5% increase year-on-year, making up 81.4% of total revenue, with a gross margin of 8.2%, down 2.8 percentage points [8]. - The cigarette export business reported revenue of HKD 552 million, a slight increase of 0.8% year-on-year, with a gross margin of 25.7%, up 3.5 percentage points [8]. - The new tobacco products export business saw a significant decline in revenue, down 66.5% year-on-year to HKD 15 million, accounting for 0.1% of total revenue [8]. - The Brazilian operations generated revenue of HKD 195 million, down 50.3% year-on-year, with a gross margin of 27.4%, up 10.2 percentage points [8]. Business Model and Competitive Advantage - The company holds a rare exclusive operating right for international tobacco business, which is expected to provide continued benefits from overseas expansion and mergers and acquisitions [2][3]. - The business model is characterized by strong cash flow and high bargaining power, supported by a stable revenue growth trend due to existing pricing policies [2][3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's main business performance is robust and exceeds expectations, with operational efficiency supporting a relatively stable net profit margin [8] - The company is positioned as the only listed entity under China Tobacco International, focusing on the import and export of tobacco leaf products, which are showing steady growth [8] - Despite short-term pressures on Brazilian operations and new tobacco products, there is potential for further integration of overseas industry chain resources [8] - The company has adjusted its profit forecasts upwards, expecting attributable net profits of HKD 9.4 billion, 10.4 billion, and 12.1 billion for 2025-2027, respectively [8] Financial Performance Summary - Total revenue for 2023 is projected at HKD 11,836 million, with a year-on-year growth of 42.19% [1] - The attributable net profit for 2023 is expected to be HKD 598.77 million, reflecting a year-on-year increase of 59.71% [1] - The earnings per share (EPS) for 2023 is estimated at HKD 0.87, with a price-to-earnings (P/E) ratio of 43.83 [1] - The company anticipates a total revenue of HKD 14,856 million for 2025, representing a year-on-year growth of 13.63% [1] - The attributable net profit for 2025 is projected at HKD 938.26 million, with a year-on-year growth of 9.90% [1] - The EPS for 2025 is expected to be HKD 1.36, with a P/E ratio of 27.97 [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a steady growth in performance for the first half of 2025, with a focus on enhancing its core competitiveness [4][5] - The company aims to improve its differentiated and customized service system, optimize product pricing strategies, and enhance profitability in its tobacco leaf business [5] - The company is actively expanding its international business and capital market operations, positioning itself as a key player in the global tobacco industry [8] Financial Performance Summary - For the first half of 2025, the company achieved a revenue of HKD 10.316 billion, representing a year-on-year growth of 18.5% [6] - The gross profit was HKD 946 million, a decrease of 1.8% year-on-year, while the net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year [6] - The company declared an interim dividend of HKD 0.19 per share, an increase of 26.7% year-on-year [6] Business Segment Analysis - Tobacco leaf import business: Import volume of 97,900 tons, up 2.5% year-on-year; revenue of HKD 8.399 billion, up 23.5% year-on-year; gross profit of HKD 687 million, down 7.7% year-on-year [6] - Tobacco leaf export business: Export volume of 38,500 tons, up 12.7% year-on-year; revenue of HKD 1.156 billion, up 25.9% year-on-year; gross profit of HKD 63 million, up 124.1% year-on-year [6] - Cigarette export business: Export volume of 1.019 billion sticks, down 7.9% year-on-year; revenue of HKD 552 million, up 0.8% year-on-year; gross profit of HKD 142 million, up 16.8% year-on-year [6] - New tobacco product export business: Export volume of 81 million sticks, down 65.4% year-on-year; revenue of HKD 15 million, down 66.5% year-on-year; gross profit of HKD 0.8 million, down 62.4% year-on-year [6] - Brazilian operations: Export volume of 7,900 tons, down 34.8% year-on-year; revenue of HKD 195 million, down 50.3% year-on-year; gross profit of HKD 54 million, down 21.0% year-on-year [6] Future Financial Projections - Projected total revenue for 2025-2027: HKD 14.911 billion (2025), HKD 16.241 billion (2026), HKD 17.518 billion (2027) with year-on-year growth rates of 14%, 9%, and 8% respectively [8] - Projected net profit attributable to shareholders for 2025-2027: HKD 940 million (2025), HKD 1.058 billion (2026), HKD 1.163 billion (2027) with year-on-year growth rates of 10%, 13%, and 10% respectively [8] - Corresponding EPS for 2025-2027: HKD 1.36 (2025), HKD 1.53 (2026), HKD 1.68 (2027) with corresponding P/E ratios of 27.92, 24.80, and 22.56 respectively [8]